Reply to: Sentinel node biopsy after neoadjuvant chemotherapy for breast cancer in patients with pre-treatment node-positive: Recommendation to optimize the performance.

Autor: Simons JM; Erasmus Medical Center Rotterdam, Department of Surgical Oncology, Rotterdam, the Netherlands; University Medical Center Utrecht, Department of Surgical Oncology, Utrecht, the Netherlands. Electronic address: j.m.simons@umcutrecht.nl., Maaskant-Braat AJG; Maxima Medisch Centrum, Department of Surgical Oncology, Eindhoven, the Netherlands., Luiten EJT; Amphia Hospital, Department of Surgical Oncology, Breda, the Netherlands., Leidenius MH; Helsinki University Hospital, Department of Breast Surgery, Helsinki, Finland., van Nijnatten TJA; Maastricht University Medical Center+, Department of Radiology and Nuclear Medicine, Maastricht, the Netherlands., Boelens PG; Leiden University Medical Center, Department of Surgery, Leiden, the Netherlands., Koppert LB; Erasmus Medical Center Rotterdam, Department of Surgical Oncology, Rotterdam, the Netherlands., van der Pol CC; Alrijne Hospital, Department of Surgical Oncology, Leiderdorp, the Netherlands., van de Velde CJH; Leiden University Medical Center, Department of Surgery, Leiden, the Netherlands., Audisio RA; Institute of Clinical Sciences, Sahlgrenska University Hospital, Department of Surgery, Göteborg, Sweden., Smidt ML; Maastricht University Medical Center+, Department of Surgical Oncology, Maastricht, the Netherlands; Maastricht University Medical Center+, GROW - School for Oncology and Developmental Biology, Maastricht, the Netherlands.
Jazyk: angličtina
Zdroj: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology [Eur J Surg Oncol] 2020 Jan; Vol. 46 (1), pp. 218-219. Date of Electronic Publication: 2019 Oct 22.
DOI: 10.1016/j.ejso.2019.10.022
Databáze: MEDLINE